On Friday, Transmedics Group Inc (NASDAQ: TMDX) opened lower -3.77% from the last session, before settling in for the closing price of $145.99. Price fluctuations for TMDX have ranged from $36.42 to $156.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 95.07%. Company’s average yearly earnings per share was noted 206.12% at the time writing. With a float of $31.79 million, this company’s outstanding shares have now reached $32.67 million.
The extent of productivity of a business whose workforce counts for 584 workers is very important to gauge.
Transmedics Group Inc (TMDX) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Transmedics Group Inc is 3.49%, while institutional ownership is 105.47%. The most recent insider transaction that took place on Jul 15 ’24, was worth 1,252,051. In this transaction President & CEO of this company sold 8,625 shares at a rate of $145.17, taking the stock ownership to the 61,643 shares. Before that another transaction happened on Jul 01 ’24, when Company’s Chief Commercial Officer sold 2,958 for $151.40, making the entire transaction worth $447,853. This insider now owns 20,843 shares in total.
Transmedics Group Inc (TMDX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 206.12% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Check out the current performance indicators for Transmedics Group Inc (TMDX). In the past quarter, the stock posted a quick ratio of 8.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.34, a number that is poised to hit 0.21 in the next quarter and is forecasted to reach 1.17 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
The latest stats from [Transmedics Group Inc, TMDX] show that its last 5-days average volume of 0.55 million was inferior to 0.74 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 33.75%. Additionally, its Average True Range was 7.30.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 82.04%, which indicates a significant increase from 28.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.87% in the past 14 days, which was lower than the 58.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $142.90, while its 200-day Moving Average is $94.39. Now, the first resistance to watch is $147.40. This is followed by the second major resistance level at $154.32. The third major resistance level sits at $159.16. If the price goes on to break the first support level at $135.64, it is likely to go to the next support level at $130.80. Assuming the price breaks the second support level, the third support level stands at $123.88.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
There are currently 32,937K shares outstanding in the company with a market cap of 4.63 billion. Presently, the company’s annual sales total 241,620 K according to its annual income of -25,030 K. Last quarter, the company’s sales amounted to 96,850 K and its income totaled 12,200 K.
